Wird geladen...
Targeted Therapies in HER2-Overexpressing Metastatic Breast Cancer
Human epidermal growth factor receptor-2 (HER2) is amplified in 25-30% of breast cancers and is associated with aggressive disease and poorer survival. Multiple anti-HER2 targeted therapies have dramatically changed management and outcome of this subgroup, both in adjuvant and metastatic settings. D...
Gespeichert in:
| Veröffentlicht in: | Breast Care (Basel) |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
S. Karger GmbH
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5290449/ https://ncbi.nlm.nih.gov/pubmed/28228709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000452194 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|